508 related articles for article (PubMed ID: 14551894)
1. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
Dorsey G; Vlahos J; Kamya MR; Staedke SG; Rosenthal PJ
J Infect Dis; 2003 Oct; 188(8):1231-8. PubMed ID: 14551894
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
[TBL] [Abstract][Full Text] [Related]
3. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
[TBL] [Abstract][Full Text] [Related]
4. Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
Hamour S; Melaku Y; Keus K; Wambugu J; Atkin S; Montgomery J; Ford N; Hook C; Checchi F
Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):548-54. PubMed ID: 15869770
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
[TBL] [Abstract][Full Text] [Related]
6. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate.
Rwagacondo CE; Niyitegeka F; Sarushi J; Karema C; Mugisha V; Dujardin JC; Van Overmeir C; van den Ende J; D'Alessandro U
Am J Trop Med Hyg; 2003 Jun; 68(6):743-7. PubMed ID: 12887037
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.
Mockenhaupt FP; Ehrhardt S; Dzisi SY; Teun Bousema J; Wassilew N; Schreiber J; Anemana SD; Cramer JP; Otchwemah RN; Sauerwein RW; Eggelte TA; Bienzle U
Trop Med Int Health; 2005 Jun; 10(6):512-20. PubMed ID: 15941413
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
Koram KA; Abuaku B; Duah N; Quashie N
Acta Trop; 2005 Sep; 95(3):194-203. PubMed ID: 16054584
[TBL] [Abstract][Full Text] [Related]
12. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.
Dorsey G; Njama D; Kamya MR; Cattamanchi A; Kyabayinze D; Staedke SG; Gasasira A; Rosenthal PJ
Lancet; 2002 Dec 21-28; 360(9350):2031-8. PubMed ID: 12504399
[TBL] [Abstract][Full Text] [Related]
13. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
14. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
[TBL] [Abstract][Full Text] [Related]
15. Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda.
Dorsey G; Dokomajilar C; Kiggundu M; Staedke SG; Kamya MR; Rosenthal PJ
Am J Trop Med Hyg; 2004 Dec; 71(6):758-63. PubMed ID: 15642967
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola.
Guthmann JP; Ampuero J; Fortes F; van Overmeir C; Gaboulaud V; Tobback S; Dunand J; Saraiva N; Gillet P; Franco J; Denoncin A; van Herp M; Balkan S; Dujardin JC; D'Alessandro U; Legros D
Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):485-92. PubMed ID: 15876443
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
Bonnet M; Roper C; Félix M; Coulibaly L; Kankolongo GM; Guthmann JP
Malar J; 2007 May; 6():54. PubMed ID: 17477865
[TBL] [Abstract][Full Text] [Related]
19. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.
Francis D; Nsobya SL; Talisuna A; Yeka A; Kamya MR; Machekano R; Dokomajilar C; Rosenthal PJ; Dorsey G
J Infect Dis; 2006 Apr; 193(7):978-86. PubMed ID: 16518760
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]